The Valley Desk

NCT04324021 · Interventional trial

Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.

Overall registry status Terminated

Phase 2 · Phase 3

Conditions SARS-CoV-2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov